文献速递肝病

miR-425通过上调N-Ras调控原发性胆汁性胆管炎CD4+ T细胞炎性细胞因子的产生

miR-425 regulates inflammatory cytokine production in CD4+ T cells via N-Ras upregulation in primary biliary cholangitis.
PubMed 文献 · J Hepatol · 2017-02-10

本研究对14例原发性胆汁性胆管炎(PBC)患者和10例健康对照的CD4+ T细胞进行miRNA与mRNA整合分析,发现4个与T细胞受体信号通路相关的miRNA显著下调,且均靶向N-Ras;体外实验证实miR-425下调通过上调N-Ras诱导IL-2和IFN-γ产生。

要点

  • PBC患者CD4+ T细胞中miR-181a、miR-181b、miR-374b和miR-425显著下调。
  • N-Ras是上述4个miRNA的共同靶点,参与T细胞受体信号通路调控。
  • miR-425下调通过上调N-Ras诱导IL-2和IFN-γ等炎性细胞因子产生。

核心结论

  • PBC患者CD4+ T细胞中存在4个调控TCR信号的miRNA表达下调,miR-425通过上调N-Ras作为PBC的炎性调节因子。
  • 恢复下调的miR-425或抑制N-Ras可能成为针对PBC的有前景的免疫治疗策略。

研究设计与样本

  • 对14例PBC患者和10例健康对照的CD4+ T细胞进行miRNA与mRNA整合分析,采用微阵列和qRT-PCR,并行基因集富集分析。
  • 利用报告基因和miRNA过表达实验进行miRNA功能分析。

主要发现

  • 整合分析识别出4个与T细胞受体信号通路相关的显著下调miRNA:miR-181a、miR-181b、miR-374b和miR-425,均靶向N-Ras。
  • 体外实验证实miR-425表达降低通过上调TCR信号通路中的N-Ras强烈诱导炎性细胞因子IL-2和IFN-γ产生。

临床怎么用

  • 作者认为,恢复下调的miR-425或抑制N-Ras可能是有前景的针对PBC的免疫治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Primary biliary cholangitis (PBC) is an autoimmune liver disease of unknown pathogenesis. Consequently, therapeutic targets for PBC have yet to be identified. CD4+ T cells play a pivotal role in immunological dysfunction observed in PBC, and therefore, microRNA (miRNA) and mRNA expression were analysed in CD4+ T cells, to investigate PBC pathogenesis and identify novel therapeutic targets. METHODS: Integral miRNA and mRNA analysis of 14 PBC patients and ten healthy controls was carried out using microarray and quantitative real-time polymerase chain reaction (qRT-PCR), with gene set enrichment analysis. The functional analyses of miRNA were then assessed using reporter and miRNA-overexpression assays. RESULTS: The integral analysis of miRNA and mRNA identified four significantly downregulated miRNAs (miR-181a, -181b, -374b, and -425) related to the T cell receptor (TCR) signalling pathway in CD4+ T cells of PBC. N-Ras, a regulator of the TCR signalling pathway, was found to be targeted by all four identified miRNAs. In addition, in vitro assays confirmed that decreased miR-425 strongly induced inflammatory cytokines (interleukin [IL]-2 and interferon [IFN]-γ) via N-Ras upregulation in the TCR signalling pathway. CONCLUSION: The decreased expression of four miRNAs that dysregulate TCR signalling in PBC CD4+ T cells was identified. miR-425 was demonstrated as an inflammatory regulator of PBC via N-Ras upregulation. Therefore, the restoration of decreased miR-425 or the suppression of N-Ras may be a promising immunotherapeutic strategy against PBC. LAY SUMMARY: Primary biliary cholangitis (PBC) is an autoimmune liver disease, but the causes are unknown. MicroRNAs are molecules known to regulate biological signals. In this study, four microRNAs were identified as being decreased in PBC patients, leading to activation of T cell receptor signalling pathways, involved in inflammation. One particular target, N-Ras, could be an attractive and novel immunotherapeutic option for PBC. TRANSCRIPT PROFILING: Microarray data are deposited in GEO (GEO accession: GSE93172).

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Nakagawa R, Muroyama R, Saeki C, et al. miR-425 regulates inflammatory cytokine production in CD4+ T cells via N-Ras upregulation in primary biliary cholangitis. J Hepatol. 2017. PMID: 28192189. doi:10.1016/j.jhep.2017.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。